Microbiology & Infectious Diseases

Immune checkpoint inhibitor therapy appears safe and effective for NSCLC in people living with HIV today.

Severe COVID anxiety improved for most participants over 18 months although recovery was not universal.

A new web-based assessment revealed strong but varied accuracy in interpreting Lyme disease diagnostics, underscoring the need for training and standardized interpretation across laboratories.

Despite global alerts, development of mpox therapeutics and diagnostics has failed to match the urgency of recent outbreaks.

Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.

A recent study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17 years.

RSV immunization in infants is safe and produces high antibody levels, regardless of whether mothers received vaccination during pregnancy.

A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.